- 专利标题： VIDOFLUDIMUS FOR USE IN THE TREATMENT OR PREVENTION OF VIRAL DISEASES
-
申请号： US17855945申请日： 2022-07-01
-
公开(公告)号： US20220339132A1公开(公告)日： 2022-10-27
- 发明人: Manfred GRÖPPEL , Daniel VITT , Hella KOHLHOF , Andreas MÜHLER
- 申请人： Immunic AG
- 申请人地址： DE Gräfelfing
- 专利权人： Immunic AG
- 当前专利权人： Immunic AG
- 当前专利权人地址： DE Gräfelfing
- 优先权： EP20170729.6 20200421,EP20184031.1 20200703,EP21164552.8 20210324
- 主分类号： A61K31/196
- IPC分类号： A61K31/196 ; A61P31/14 ; A61K9/00 ; A61K9/20 ; A61K31/706 ; A61K45/06
摘要：
The present invention relates to a compound according to Formula (I) or a salt, solvate and/or a hydrate thereof, wherein said compound inhibits dihydroorotate dehydrogenase (DHODH), for use in the treatment and prevention of viral infection. A preferred example is viral infection caused by coronavirus, in particular betacoronavirus, more particular SARS-CoV-2 and mutated versions thereof.
信息查询
IPC分类:
